Aluminium hydroxide

About: Aluminium hydroxide is a research topic. Over the lifetime, 2043 publications have been published within this topic receiving 22032 citations. The topic is also known as: Al(OH)3 & Amphojel.

The structural stability of protein antigens adsorbed by aluminium hydroxide in comparison to the antigens in solutions

Abstract: It is believed that antigens should be adsorbed onto adjuvants in vaccines. The adsorption-modified structure of antigens is important to understand the mechanism of adjuvants and vaccine immunogenicity. The structural stability of antigens is of major importance. The changes in structure can be induced by degradation and/or increase of storage temperature. In this study the structural stability of two model antigens, bovine serum albumin (BSA) and β-lactoglobulin (BLG) were compared when they were adsorbed onto aluminium hydroxide and when they were in solutions using Fourier transform infrared - attenuated total reflection (FTIR-ATR) spectroscopy. The structural stability of these two proteins was studied at different temperature and during storages. The present results showed that the structure of antigens can be stabilized by adsorption onto aluminium hydroxide. Non-adsorbed protein antigens present in vaccines may facilitate the degradation of the vaccine.

Establishment of experimental autoimmune prostatitis model by T2 peptide in aluminium hydroxide adjuvant.

Abstract: A mouse model was developed to simulate the clinical features of chronic prostatitis/chronic pelvic pain syndrome using peptide (T2 ). Forty C57BL/6 mice were divided into four groups of 10 mice each, averagely and randomly. T2 plus aluminium hydroxide adjuvant group was given subcutaneous injection with the emulsion mixture of T2 and aluminium hydroxide adjuvant, the T2 group with T2 , the aluminium hydroxide adjuvant group with aluminium hydroxide adjuvant and the normal control group with 0.9/% NaCl solution. Haematoxylin andeosin staining was used to observe the inflammation of the prostate. Plasma levels of TNF-α and CRP were detected by ELISA kit. The expression of IL-1βin the prostate was investigated by immunohistochemistry. The statistical differences between the groups were compared by t test. Histopathological analyses demonstrated that prostate lesions were most severe in the group immunised with T2 plus aluminium hydroxide adjuvant. Plasma levels of TNF-α and CRP were statistically elevated compared with control groups. The expression levels of IL-1β in the prostate were more obvious than control groups. T2 in aluminium hydroxide adjuvant subcutaneous injection could successfully set up experimental autoimmune prostatitis in C57BL/6 mice. This murine model would be greatly beneficial to further comprehend the aetiology, pathogenesis and explicit treatment of CP/CPPS.

Alkali-free liquid setting accelerator

Abstract: The invention discloses an alkali-free liquid setting accelerator which is prepared from the following components by weight percent: 18-40% of hydroxycarboxylic acid, 1-5% of phosphoric acid, 15-30% of aluminium hydroxide, 0-5% of alkylol amine, 001-02% of defoaming agent and the balance water The alkali-free liquid setting accelerator of invention does not contain alkali metal ions, sulfate ions and other corrosive materials, is safe to use and has no bad effect on the durability of sprayed concrete, thus being capable to be used in the construction of sprayed concrete

Preparation method of hydrotreatment catalyst

Abstract: The invention discloses a preparation method of a hydrotreatment catalyst, comprising the following steps of: introducing silicon and boron additives in the way that an organic silicon source is added after aluminium hydroxide gel forming and then a boron-containing organic compound solution is added, so as to obtain silicon and boron containing aluminium hydroxide, mixing parts of an active metal component with boron-containing aluminium hydroxide by a kneading method, carrying out three-stage roasting to obtain a catalyst intermediate, loading residual part of the active metal onto the catalyst intermediate by dipping, and drying to obtain the hydrotreatment catalyst. By the adoption of the method provided by the invention, the silicon and boron additives and the active metal component are uniformly distributed on the surface of the catalyst. In addition, the active metal component has different existing forms in the catalyst when introduced in the two modes, loss rate of the catalyst activity is reduced by mutual cooperation, and running period of a device is prolonged. The catalyst has large pore volume, large specific surface area, appropriate pore structure and acidity, and is especially suitable for hydrodenitrogenation process of heavy hydrocarbon.